StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): study protocol for a randomised controlled clinical trial

BACKGROUND: The standard of care for neovascular age-related macular degeneration (nAMD) involves ongoing intravitreal injections of anti-angiogenic drugs targeting vascular endothelial growth factor (VEGF). The most commonly used anti-VEGF drugs are ranibizumab, bevacizumab and aflibercept. The mai...

Descripción completa

Detalles Bibliográficos
Autores principales: Neffendorf, James E., Desai, Riti, Wang, Yanzhong, Kelly, Joanna, Murphy, Caroline, Reeves, Barnaby C., Chakravarthy, Usha, Wordsworth, Sarah, Lewis, Cornelius, Peacock, Janet, Uddin, Shahir, O’Sullivan, Joe M., Jackson, Timothy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121938/
https://www.ncbi.nlm.nih.gov/pubmed/27881184
http://dx.doi.org/10.1186/s13063-016-1676-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121938/
https://www.ncbi.nlm.nih.gov/pubmed/27881184
http://dx.doi.org/10.1186/s13063-016-1676-7

Ejemplares similares